Jazz Pharmaceuticals plc buy Robert W. Baird
Start price
18.11.25
/
50%
€153.10
Target price
18.11.26
€180.30
Performance (%)
-6.14%
Price
23.12.25
€143.70
Summary
This prediction is currently active. With a performance of -6.14%, the BUY prediction for Jazz Pharmaceuticals plc by Robert_W__Baird is down slightly. This prediction currently runs until 18.11.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 1.519% | 1.519% |
| iShares Core DAX® | 0.650% | 3.212% |
| iShares Nasdaq 100 | 1.650% | 0.322% |
| iShares Nikkei 225® | 1.232% | 1.549% |
| iShares S&P 500 | 1.413% | 0.282% |
Comments by Robert_W__Baird for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at Robert W. Baird from $160.00 to $209.00. They now have an "outperform" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Robert_W__Baird for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€89.70
07.05.25
07.05.25
€136.63
07.05.26
07.05.26
60.20%
23.12.25
23.12.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€114.85
18.11.24
18.11.24
€153.25
18.11.25
18.11.25
33.87%
19.11.25
19.11.25
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€116.65
03.01.24
03.01.24
€146.46
03.01.25
03.01.25
-0.60%
04.01.25
04.01.25